市場調查報告書
商品編碼
1495467
內閉合裝置市場:依產品、最終用戶分類 - 2024-2030 年全球預測Endoscopic Closure Devices Market by Product (Band Ligators, Clips, Suturing Devices), End-user (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年內閉合裝置市場規模為5.0975億美元,預計2024年將達到5.3815億美元,2030年將達到7.6093億美元,複合年成長率為5.88%。
內視鏡閉合裝置用於在內視鏡手術期間或之後閉合胃腸道中的穿孔、切口和管腔。這些工具對於內視鏡切除、胃腸道缺陷治療以及需要暫時或永久閉合腸壁開口的手術等手術至關重要。胃腸道疾病的日益普及增加了相關手術的偏好,導致內視鏡閉合裝置閉合裝置的需求不斷擴大。先進內視鏡閉合裝置的高成本阻礙了市場成長。具有能夠與醫療保健系統整合以實現更好的資料管理和病患監測功能的內視鏡閉合裝置市場正在開拓中,預計將為市場成長創造機會。
主要市場統計 | |
---|---|
基準年[2023] | 50975萬美元 |
預測年份 [2024] | 5.3815億美元 |
預測年份 [2030] | 76093萬美元 |
複合年成長率(%) | 5.88% |
區域洞察
由於先進的醫療基礎設施和消化器官系統手術的高發生率,美洲是內視鏡閉合裝置不斷成長的市場。美洲消費者對微創手術的認知更加深刻,對內視鏡閉合裝置的需求也日益成長。南美洲內視閉合裝置市場得到了政府和私營部門旨在減少手術時間和改善恢復期的舉措的支持。歐盟國家的內視鏡閉合裝置市場受到嚴格的歐盟法規的推動,這些法規確保醫療設備的品質標準和安全。在歐盟國家,由於人口老化和需要手術干預的慢性疾病的高盛行率,對內視鏡閉合裝置的需求穩定。最近的舉措包括歐盟資助創新手術技術和設備改進的研究。中東受益於海灣合作理事會國家豐富的經濟,這些國家在衛生基礎設施方面進行了大量投資。非洲雖然在衛生設施方面仍不發達,但由於越來越重視衛生改革和外國投資,因此被視為充滿希望。由於政府旨在提高醫療保健標準的措施和不斷成長的中階人口,亞太地區內視鏡閉合裝置市場正在迅速擴大。亞太地區對預防性醫療保健和先進手術設備的投資大幅增加,為該地區的市場成長奠定了基礎。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在內視閉合裝置市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對內視鏡閉合裝置市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析也為此細分市場的競爭性質提供了寶貴的見解,包括研究的累積時間、片段化主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在內視鏡閉合裝置市場中的地位進行全面評估將幫助公司做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[197 Pages Report] The Endoscopic Closure Devices Market size was estimated at USD 509.75 million in 2023 and expected to reach USD 538.15 million in 2024, at a CAGR 5.88% to reach USD 760.93 million by 2030.
Endoscopic closure devices are used to close perforations, incisions, or lumens in the gastrointestinal tract during or after endoscopic procedures. These tools are crucial for procedures such as endoscopic resections, treatment of gastrointestinal defects, and surgeries that require temporary or permanent closure of an opening in the gut wall. The increasing prevalence of gastrointestinal diseases is raising the need for relevant surgeries and, consequently, endoscopic closure devices. Growing preference for minimally invasive procedures that promote faster recovery and reduce hospital stays is expanding the need for endoscopic closure devices. The high cost of advanced endoscopic closure devices hampers the market growth. The growing development of endoscopic closure devices equipped with features that allow integration with health systems for better data management and patient monitoring is expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 509.75 million |
Estimated Year [2024] | USD 538.15 million |
Forecast Year [2030] | USD 760.93 million |
CAGR (%) | 5.88% |
Regional Insights
The Americas represents a growing market for endoscopic closure devices due to its advanced healthcare infrastructure and high incidence of gastrointestinal procedures. Consumers in the Americas demonstrate a high awareness of minimally invasive surgeries, subsequently increasing the need for endoscopic closure devices. The endoscopic closure devices market in South America is supported by government and private sector initiatives to reduce surgical times and improve recovery periods. The market across EU countries is driven by stringent EU regulations, which ensure high-quality standards and the safety of medical devices. There is a steady need for endoscopic closure devices in EU countries driven by an aging population and the high prevalence of chronic diseases that require surgical interventions. Recent initiatives include EU funding for research into innovative surgical techniques and device improvements. The Middle East benefits from the affluent economies of GCC countries, which invest heavily in healthcare infrastructure. Africa, while still developing in terms of healthcare facilities, shows promise due to an increasing focus on healthcare reforms and foreign investments. Asia-Pacific's market for endoscopic closure devices is rapidly expanding, driven by government initiatives aimed at improving healthcare standards and a growing middle-class population. Rising substantial investments in preventive medicine and advanced surgical devices in Asia-Pacific are creating a platform for market growth in the region.
Market Insights
The market dynamics represent an ever-changing landscape of the Endoscopic Closure Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Endoscopic Closure Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Endoscopic Closure Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Boston Scientific Expands Endoscopy Capabilities with Apollo Endosurgery Acquisition
Boston Scientific announced its acquisition of Apollo Endosurgery for gastrointestinal and endo bariatric therapies. The acquisition is a strategic enhancement that provides a broader range of endoluminal surgery (ELS) and endo-bariatric solutions. This expansion enriches their product offerings and integrates new expertise into their team, aiming to foster advancements in patient care and medical innovation. [Published On: 2023-04-11]
Substantial Investment Fuels Advancement in Endoscopic Technologies
IQ Endoscopes has garnered a significant EUR 5.2 million investment led by BGF, with contributions from the Development Bank of Wales and other investors. This financial boost is earmarked for enhancing the development and deployment of IQ Endoscope's pioneering device, aimed at transforming early detection and diagnosis of various cancers and gastrointestinal ailments. [Published On: 2023-01-25]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Endoscopic Closure Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Endoscopic Closure Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Apollo Endosurgery, Inc., Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated, CooperSurgical Inc., Duomed Group, ENDO-FLEX GmbH, EnVision Endoscopy, Johnson & Johnson Services, Inc., Leo Medical Co.,Ltd., Medorah Meditek Pvt. Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., Micro-Tech USA Incorporated, Olympus Corporation, Ovesco Endoscopy AG, Saint-Gobain S.A., SiTime Corporation, Steris plc, and Wuxi Beien Surgery Device Co., Ltd.
Market Segmentation & Coverage